The Objective of This Study is to Evaluate the Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone

NCT03739203 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

752

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: Cariprazine
DRUG: Placebo
DRUG: Antidepressant Therapy (ADT)

Sponsor

AbbVie